Serum adiponectin and type 2 diabetes

A 6-year follow-up cohort study

Sun Ha Jee, Chul Woo Ahn, Jong Suk Park, Chang Gyu Park, Hyon Suk Kim, Sang Hak Lee, Sungha Park, Myoungsook Lee, Chang Beom Lee, Hye Soon Park, Heejin Kimm, Sung Hee Choi, Jidong Sung, Seungjoon Oh, Hyojee Joung, Sung Rae Kim, Ho Joong Youn, Sun Mi Kim, Hong Soo Lee, Yejin Mok & 5 others Eunmi Choi, Young Duk Yun, Soo Jin Baek, Jaeseong Jo, Kap Bum Huh

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

TBackground: Studies on factors which may predict the risk of diabetes are scarce. This prospective cohort study was conducted to determine the association between adiponectin and type 2 diabetes among Korean men and women. Methods: A total of 42,845 participants who visited one of seven health examination centers located in Seoul and Gyeonggi province, Republic of Korea between 2004 and 2008 were included in this study. The incidence rates of diabetes were determined through December 2011. To evaluate the effects of adiponectin on type 2 diabetes, the Cox proportional hazard model was used. Results: Of the 40,005 participants, 959 developed type 2 diabetes during a 6-year follow-up. After the adjustment for age, body mass index (BMI), and waist circumference, the risks for type 2 diabetes in participants with normoglycemia had a 1.70-fold (95% confidence interval [CI], 1.21 to 2.38) increase in men and a 1.83-fold (95% CI, 1.17 to 2.86) increase in women with the lowest tertile of adiponectin when compared to the highest tertile of adiponectin. For participants with impaired fasting glucose (IFG), the risk for type 2 diabetes had a 1.46-fold (95% CI, 1.17 to 1.83) increase in men and a 2.52-fold (95% CI, 1.57 to 4.06) increase in women with the lowest tertile of adiponectin. Except for female participants with normoglycemia, all the risks remained significant after the adjustment for fasting glucose and other confounding variables. Surprisingly, BMI and waist circumference were not predictors of type 2 diabetes in men or women with IFG after adjustment for fasting glucose and other confounders. Conclusion: A strong association between adiponectin and diabetes was observed. The use of adiponectin as a predictor of type 2 diabetes is considered to be useful.

Original languageEnglish
Pages (from-to)252-261
Number of pages10
JournalDiabetes and Metabolism Journal
Volume37
Issue number4
DOIs
Publication statusPublished - 2013 Sep 23

Fingerprint

Adiponectin
Type 2 Diabetes Mellitus
Cohort Studies
Serum
Fasting
Confidence Intervals
Glucose
Waist Circumference
Body Mass Index
Republic of Korea
Confounding Factors (Epidemiology)
blood group A active hexaglycosylceramide type 2 chain
Proportional Hazards Models
Prospective Studies
Incidence
Health

Keywords

  • Adiponectin
  • Cohort studies
  • Diabetes mellitus
  • Impaired fasting glucose

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Jee, S. H., Ahn, C. W., Park, J. S., Park, C. G., Kim, H. S., Lee, S. H., ... Huh, K. B. (2013). Serum adiponectin and type 2 diabetes: A 6-year follow-up cohort study. Diabetes and Metabolism Journal, 37(4), 252-261. https://doi.org/10.4093/dmj.2013.37.4.252

Serum adiponectin and type 2 diabetes : A 6-year follow-up cohort study. / Jee, Sun Ha; Ahn, Chul Woo; Park, Jong Suk; Park, Chang Gyu; Kim, Hyon Suk; Lee, Sang Hak; Park, Sungha; Lee, Myoungsook; Lee, Chang Beom; Park, Hye Soon; Kimm, Heejin; Choi, Sung Hee; Sung, Jidong; Oh, Seungjoon; Joung, Hyojee; Kim, Sung Rae; Youn, Ho Joong; Kim, Sun Mi; Lee, Hong Soo; Mok, Yejin; Choi, Eunmi; Yun, Young Duk; Baek, Soo Jin; Jo, Jaeseong; Huh, Kap Bum.

In: Diabetes and Metabolism Journal, Vol. 37, No. 4, 23.09.2013, p. 252-261.

Research output: Contribution to journalArticle

Jee, SH, Ahn, CW, Park, JS, Park, CG, Kim, HS, Lee, SH, Park, S, Lee, M, Lee, CB, Park, HS, Kimm, H, Choi, SH, Sung, J, Oh, S, Joung, H, Kim, SR, Youn, HJ, Kim, SM, Lee, HS, Mok, Y, Choi, E, Yun, YD, Baek, SJ, Jo, J & Huh, KB 2013, 'Serum adiponectin and type 2 diabetes: A 6-year follow-up cohort study', Diabetes and Metabolism Journal, vol. 37, no. 4, pp. 252-261. https://doi.org/10.4093/dmj.2013.37.4.252
Jee, Sun Ha ; Ahn, Chul Woo ; Park, Jong Suk ; Park, Chang Gyu ; Kim, Hyon Suk ; Lee, Sang Hak ; Park, Sungha ; Lee, Myoungsook ; Lee, Chang Beom ; Park, Hye Soon ; Kimm, Heejin ; Choi, Sung Hee ; Sung, Jidong ; Oh, Seungjoon ; Joung, Hyojee ; Kim, Sung Rae ; Youn, Ho Joong ; Kim, Sun Mi ; Lee, Hong Soo ; Mok, Yejin ; Choi, Eunmi ; Yun, Young Duk ; Baek, Soo Jin ; Jo, Jaeseong ; Huh, Kap Bum. / Serum adiponectin and type 2 diabetes : A 6-year follow-up cohort study. In: Diabetes and Metabolism Journal. 2013 ; Vol. 37, No. 4. pp. 252-261.
@article{18b91b0e1c654147a84366930f5577e0,
title = "Serum adiponectin and type 2 diabetes: A 6-year follow-up cohort study",
abstract = "TBackground: Studies on factors which may predict the risk of diabetes are scarce. This prospective cohort study was conducted to determine the association between adiponectin and type 2 diabetes among Korean men and women. Methods: A total of 42,845 participants who visited one of seven health examination centers located in Seoul and Gyeonggi province, Republic of Korea between 2004 and 2008 were included in this study. The incidence rates of diabetes were determined through December 2011. To evaluate the effects of adiponectin on type 2 diabetes, the Cox proportional hazard model was used. Results: Of the 40,005 participants, 959 developed type 2 diabetes during a 6-year follow-up. After the adjustment for age, body mass index (BMI), and waist circumference, the risks for type 2 diabetes in participants with normoglycemia had a 1.70-fold (95{\%} confidence interval [CI], 1.21 to 2.38) increase in men and a 1.83-fold (95{\%} CI, 1.17 to 2.86) increase in women with the lowest tertile of adiponectin when compared to the highest tertile of adiponectin. For participants with impaired fasting glucose (IFG), the risk for type 2 diabetes had a 1.46-fold (95{\%} CI, 1.17 to 1.83) increase in men and a 2.52-fold (95{\%} CI, 1.57 to 4.06) increase in women with the lowest tertile of adiponectin. Except for female participants with normoglycemia, all the risks remained significant after the adjustment for fasting glucose and other confounding variables. Surprisingly, BMI and waist circumference were not predictors of type 2 diabetes in men or women with IFG after adjustment for fasting glucose and other confounders. Conclusion: A strong association between adiponectin and diabetes was observed. The use of adiponectin as a predictor of type 2 diabetes is considered to be useful.",
keywords = "Adiponectin, Cohort studies, Diabetes mellitus, Impaired fasting glucose",
author = "Jee, {Sun Ha} and Ahn, {Chul Woo} and Park, {Jong Suk} and Park, {Chang Gyu} and Kim, {Hyon Suk} and Lee, {Sang Hak} and Sungha Park and Myoungsook Lee and Lee, {Chang Beom} and Park, {Hye Soon} and Heejin Kimm and Choi, {Sung Hee} and Jidong Sung and Seungjoon Oh and Hyojee Joung and Kim, {Sung Rae} and Youn, {Ho Joong} and Kim, {Sun Mi} and Lee, {Hong Soo} and Yejin Mok and Eunmi Choi and Yun, {Young Duk} and Baek, {Soo Jin} and Jaeseong Jo and Huh, {Kap Bum}",
year = "2013",
month = "9",
day = "23",
doi = "10.4093/dmj.2013.37.4.252",
language = "English",
volume = "37",
pages = "252--261",
journal = "Diabetes and Metabolism Journal",
issn = "2233-6079",
publisher = "Korean Diabetes Association",
number = "4",

}

TY - JOUR

T1 - Serum adiponectin and type 2 diabetes

T2 - A 6-year follow-up cohort study

AU - Jee, Sun Ha

AU - Ahn, Chul Woo

AU - Park, Jong Suk

AU - Park, Chang Gyu

AU - Kim, Hyon Suk

AU - Lee, Sang Hak

AU - Park, Sungha

AU - Lee, Myoungsook

AU - Lee, Chang Beom

AU - Park, Hye Soon

AU - Kimm, Heejin

AU - Choi, Sung Hee

AU - Sung, Jidong

AU - Oh, Seungjoon

AU - Joung, Hyojee

AU - Kim, Sung Rae

AU - Youn, Ho Joong

AU - Kim, Sun Mi

AU - Lee, Hong Soo

AU - Mok, Yejin

AU - Choi, Eunmi

AU - Yun, Young Duk

AU - Baek, Soo Jin

AU - Jo, Jaeseong

AU - Huh, Kap Bum

PY - 2013/9/23

Y1 - 2013/9/23

N2 - TBackground: Studies on factors which may predict the risk of diabetes are scarce. This prospective cohort study was conducted to determine the association between adiponectin and type 2 diabetes among Korean men and women. Methods: A total of 42,845 participants who visited one of seven health examination centers located in Seoul and Gyeonggi province, Republic of Korea between 2004 and 2008 were included in this study. The incidence rates of diabetes were determined through December 2011. To evaluate the effects of adiponectin on type 2 diabetes, the Cox proportional hazard model was used. Results: Of the 40,005 participants, 959 developed type 2 diabetes during a 6-year follow-up. After the adjustment for age, body mass index (BMI), and waist circumference, the risks for type 2 diabetes in participants with normoglycemia had a 1.70-fold (95% confidence interval [CI], 1.21 to 2.38) increase in men and a 1.83-fold (95% CI, 1.17 to 2.86) increase in women with the lowest tertile of adiponectin when compared to the highest tertile of adiponectin. For participants with impaired fasting glucose (IFG), the risk for type 2 diabetes had a 1.46-fold (95% CI, 1.17 to 1.83) increase in men and a 2.52-fold (95% CI, 1.57 to 4.06) increase in women with the lowest tertile of adiponectin. Except for female participants with normoglycemia, all the risks remained significant after the adjustment for fasting glucose and other confounding variables. Surprisingly, BMI and waist circumference were not predictors of type 2 diabetes in men or women with IFG after adjustment for fasting glucose and other confounders. Conclusion: A strong association between adiponectin and diabetes was observed. The use of adiponectin as a predictor of type 2 diabetes is considered to be useful.

AB - TBackground: Studies on factors which may predict the risk of diabetes are scarce. This prospective cohort study was conducted to determine the association between adiponectin and type 2 diabetes among Korean men and women. Methods: A total of 42,845 participants who visited one of seven health examination centers located in Seoul and Gyeonggi province, Republic of Korea between 2004 and 2008 were included in this study. The incidence rates of diabetes were determined through December 2011. To evaluate the effects of adiponectin on type 2 diabetes, the Cox proportional hazard model was used. Results: Of the 40,005 participants, 959 developed type 2 diabetes during a 6-year follow-up. After the adjustment for age, body mass index (BMI), and waist circumference, the risks for type 2 diabetes in participants with normoglycemia had a 1.70-fold (95% confidence interval [CI], 1.21 to 2.38) increase in men and a 1.83-fold (95% CI, 1.17 to 2.86) increase in women with the lowest tertile of adiponectin when compared to the highest tertile of adiponectin. For participants with impaired fasting glucose (IFG), the risk for type 2 diabetes had a 1.46-fold (95% CI, 1.17 to 1.83) increase in men and a 2.52-fold (95% CI, 1.57 to 4.06) increase in women with the lowest tertile of adiponectin. Except for female participants with normoglycemia, all the risks remained significant after the adjustment for fasting glucose and other confounding variables. Surprisingly, BMI and waist circumference were not predictors of type 2 diabetes in men or women with IFG after adjustment for fasting glucose and other confounders. Conclusion: A strong association between adiponectin and diabetes was observed. The use of adiponectin as a predictor of type 2 diabetes is considered to be useful.

KW - Adiponectin

KW - Cohort studies

KW - Diabetes mellitus

KW - Impaired fasting glucose

UR - http://www.scopus.com/inward/record.url?scp=84884234230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884234230&partnerID=8YFLogxK

U2 - 10.4093/dmj.2013.37.4.252

DO - 10.4093/dmj.2013.37.4.252

M3 - Article

VL - 37

SP - 252

EP - 261

JO - Diabetes and Metabolism Journal

JF - Diabetes and Metabolism Journal

SN - 2233-6079

IS - 4

ER -